The newly approved oral GLP-1 drug works by: Reducing appetite Slowing digestion Improving blood sugar control Unlike injections, this pill offers: Easier daily use Greater accessibility Wider adoption potential This could change the entire weight loss market in 2026
Because it is so small, the physical sensation is minimal
Living with diabetes and taking insulin
On average, we pass gas 13 to 21 times a day, either through the mouth (i.e
Based on experience with similar incretin-based therapies, diarrhoea following a retatrutide dose increase may begin to settle within one to two weeks as the gut adapts
8 A prospective cohort study involving seven psoriasis patients with type 2 diabetes treated with liraglutide for 12 weeks observed a mean PASI decrease from 15.7 to 2.2 and a DLQI improvement from 21.8 to 4.1.9 Additionally, reductions in HbA1c, BMI, and waist circumference were observed.9 One randomized, placebo-controlled trial involving 20 obese, glucose-tolerant patients with plaque psoriasis, however, found no significant improvement in PASI after 8 weeks of liraglutide